Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools-Reference-Cited by-同舟云学术

Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools

Published:2017-10-17 Issue:10 Volume:12 Page:e0185976
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Makino Tomohiro^ORCID,Nakamura Ryuichi,Terakawa Maki,Muneoka Satoshi,Nagahira Kazuhiro,Nagane Yuriko,Yamate Jyoji,Motomura Masakatsu,Utsugisawa Kimiaki

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. Myasthenia gravis: a clinical-immunological update;S Binks;J Neurol,2016

2. Myasthenia Gravis: paradox versus paradigm in autoimmunity;S Berrih-Aknin;J Autoimmun,2014

3. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms;S Berrih-Aknin;J Autoimmun,2014

4. Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4;JJ Verschuuren;Autoimmun Rev,2013

5. Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis;MG Huijbers;J Intern Med,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of regulatory T cells in pathogenesis and therapeutics of myasthenia gravis;Regulatory T Cells and Autoimmune Diseases;2024

2. Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology;Acta Neuropathologica;2023-06-21

3. “Untargeting” autoantibodies using genome editing, a proof-of-concept study;Clinical Immunology;2023-06

4. Molecular disease mechanisms of human antineuronal monoclonal autoantibodies;Trends in Molecular Medicine;2023-01

5. Complement and myasthenia gravis;Molecular Immunology;2022-11